Related Experiment Video
Updated: Jun 13, 2025

Mechanical Stimulation-induced Calcium Wave Propagation in Cell Monolayers: The Example of Bovine Corneal Endothelial Cells
Published on: July 16, 2013
Connexin Hemichannel Inhibition and Human Genodermatoses.
Fabio Mammano1, Amy S Paller2, Thomas W White3
1Institute of Biochemistry and Cell Biology, Italian National Research Council, Rome, Italy; Department of Physics and Astronomy "G. Galilei", University of Padova, Padova, Italy.
Pathogenic variants in connexin genes elevate hemichannel activity, causing skin diseases like KID syndrome and hidrotic ectodermal dysplasia (HED). Inhibiting this activity offers a promising therapeutic strategy for these conditions.
Area of Science:
- Genetics
- Dermatology
- Biophysics
Background:
- Pathogenic variants in connexin genes cause rare genetic skin disorders.
- These disorders, including keratitis-ichthyosis-deafness (KID) syndrome and hidrotic ectodermal dysplasia (HED), are characterized by increased hemichannel activity.
- Understanding the biophysical mechanisms of variant connexins is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of increased hemichannel activity in connexin-related skin diseases.
- To evaluate the therapeutic potential of inhibiting aberrant hemichannel function.
- To explore applications for other genetic skin conditions involving elevated hemichannel activity.
Main Methods:
- Biophysical studies of variant connexins to elucidate disease mechanisms.
- Pharmacological inhibition of hemichannel activity.
- Utilizing engineered monoclonal antibodies (mAbs) in mouse models of HED and KID.
Main Results:
- Pathogenic variants in connexin genes lead to heightened hemichannel activity.
- Inhibition of this acquired hemichannel activity demonstrated potential to alleviate epidermal pathology in mouse models.
- Pharmacological blockers and mAbs effectively targeted hemichannel function.
Conclusions:
- Inhibiting elevated hemichannel activity is a viable therapeutic strategy for KID syndrome and HED.
- This approach holds promise for treating other connexin-based genetic skin diseases.
- Further research into connexin hemichannel modulation could lead to novel treatments.
Related Concept Videos
Cohesins
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of...
Gap Junctions
Pleiotropy
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Gene Conversion
Ligand-Gated Ion Channel Receptor: Gating Mechanism

